2373 — Beauty Farm Medical & Health Industry Income Statement
0.000.00%
- HK$3.97bn
- HK$2.83bn
- CNY2.57bn
- 71
- 51
- 80
- 79
Annual income statement for Beauty Farm Medical & Health Industry, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,503 | 1,781 | 1,635 | 2,145 | 2,572 |
Cost of Revenue | |||||
Gross Profit | 700 | 834 | 718 | 977 | 1,190 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,290 | 1,503 | 1,483 | 1,854 | 2,250 |
Operating Profit | 213 | 278 | 152 | 291 | 322 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 189 | 255 | 130 | 288 | 318 |
Provision for Income Taxes | |||||
Net Income After Taxes | 152 | 208 | 111 | 230 | 252 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 151 | 193 | 103 | 216 | 228 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 151 | 193 | 103 | 216 | 228 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.67 | 0.891 | 0.57 | 0.941 | 1.03 |
Dividends per Share |